Overview
William G. Kaelin Jr. is a hypoxia & tumor biology specialist with an H-index of 189 at Dana-Farber Cancer Institute (Faculty). Has been published in Hematology, transfusion and cell therapy, Ecancermedicalscience, Science (New York, N.Y.). Based in United States.
Biography
William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins.
In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award.
He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
CellScienceNat Med
Key Publications
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy.
The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins.
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
Targeting the HIF2-VEGF axis in renal cell carcinoma.
Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB.
Areas of Expertise
Medical Specialties
Media Archive